Cancer Type List

The ICRP Partners code all awards in the database to one or more of the following cancer types:

Cancer Type	ICRP Code	ICD-10 Code	Description
Not Site-Specific Cancer	2		Includes fundamental research (fluids, secretions, milk lymph, blood components, cell lines and cell fractions, etc.) and research that applies to all types of cancer.
Adrenocortical Cancer	0	C74.0
Anal Cancer	103	C21
Bladder Cancer	3	C67
Blood Cancer	67	C88, C96 (excluding C96.2, C96.3)	Use this code for Blood Cancers other than: Hodgkin's Disease (24), Leukemia / Leukaemia (27), Myeloma (30), Non-Hodgkin's Lymphoma (35)
Bone Cancer, Osteosarcoma / Malignant Fibrous Histiocytoma	4	C40, C41	Includes Osteosarcoma, Malignant Fibrous Histiocytoma, Ewing?s sarcoma and all other bone/cartilaginous tumors.
Bone Marrow Transplantation	5
Brain Tumor	6	C71	Includes Chordoma
Breast Cancer	7	C50
Cervical Cancer	9	C53
Colon and Rectal Cancer	64	C18, C19, C20
Ear Cancer	10	C30.1
Endometrial Cancer	11	C54
Esophageal / Oesophageal Cancer	12	C15
Eye Cancer	13	C69 (excluding C69.2)	Not including Retinoblastoma (45)
Gallbladder Cancer	14	C23
Gastrointestinal Tract	15	C26.9	Use this code for GI cancers other than: Colon and Rectal (64), Esophogeal /Oesophageal (12) , Gallbladder (14), Liver (23), Pancreatic (37), Small Intestine (50), Stomach (51). The computer program will automatically map these sites to GI cancers.
Genital System, Female	17	C57	Use this code for genital system, female cancers other than: Cervical (9), Endometrial (11), Ovarian (66), Vaginal (57), Vulva (101). The computer program will automatically map these sites to this category.
Genital System, Male	19	C63	Use this code for genital system, male cancers other than: Penile (39), Prostate (42), Testicular (52) cancers. The computer program will automatically map these cancer sites to this category.
Head and Neck Cancer	21	C76.0	Use this code for head and neck cancers other than: Laryngeal (26), Nasal Cavity and Paranasal Sinus (31), Oral Cavity and Lip (36), Parathyroid (38), Pharyngeal (61), Salivary Gland (63), and Thyroid (54) cancers. The computer program will automatically map these cancer sites to this category.
Heart Cancer	8	C38.0
Hodgkin's Disease	24	C81
Kaposi's Sarcoma	46	C46
Kidney Cancer	25	C64	Includes Kidney cancer and Wilm's tumor (60)
Laryngeal Cancer	26	C32
Leukemia / Leukaemia	27	C91, C92, C93, C94, C95	Including ALL, AML, CLL, CML & Hairy Cell Leukaemia, Myelodysplastic Syndrome and Myeloproliferative disorders
Liver Cancer	23	C22	Including Bile Duct
Lung Cancer	28	C34, C45	Including Mesothelioma
Melanoma	29	C43
Myeloma	30	C90	Including Multiple Myeloma
Nasal Cavity and Paranasal Sinus Cancer	31	C30.0, C31
Nervous System	33		Use this for nervous system cancers other than: Brain (6), Eye (13), Neuroblastoma (32), Pituitary (40), Primary CNS Lymphoma (104) and Retinoblastoma (45). The computer program will automatically map these cancers to this category.
Neuroblastoma	32	C74.9
Non-Hodgkin's Lymphoma	35	C82, C83, C84, C85, C96.3
Oral Cavity and Lip Cancer	36	C00, C01, C02, C03, C04, C05, C06, C09
Ovarian Cancer	66	C56
Pancreatic Cancer	37	C25
Parathyroid Cancer	38	C75.0
Penile Cancer	39	C60
Pharyngeal Cancer	61	C14.0
Pituitary Tumor	40	C75.1
Primary CNS Lymphoma	104
Primary of Unknown Origin	102
Prostate Cancer	42	C61
Respiratory System	43	C39	Use this code for respiratory cancers other than: Lung (28), Nasal Cavity & Paranasal Sinus (31) cancers. The computer program will automatically map these cancers to this category.
Retinoblastoma	45	C69.2
Salivary Gland Cancer	63	C07, C08
Sarcoma	105	C49	Includes Fibrosarcoma, Rhabdomyosarcoma, leiomyosarcoma, liposarcoma, muscle and other Soft Tissue Sarcoma (but not Ewing?s Sarcoma or other bone/cartilaginous tumors (4), or Kaposi?s Sarcoma (46))
Sarcoma, Rhabdomyosarcoma, Childhood	47
Sarcoma, Soft Tissue	48
Skin Cancer	49	C44
Small Intestine Cancer	50	C17
Stomach Cancer	51	C16
Testicular Cancer	52	C62
Thymoma, Malignant	53	C37
Thyroid Cancer	54	C73
Urinary System	55	C65, C66, C68	Use this code for urinary cancers other than: Bladder (3), Kidney or Wilm's tumor (25). The computer program will automatically map these cancer sites to this category
Vaginal Cancer	57	C52
Vascular System	58
Vulva Cancer	101	C51
Wilms' Tumor	60
Uncoded	99

Single-funder organizations
Partner	Caveat
ACS	Dollar amounts found in the ICRP database are different than what is reported in the American Cancer Society's Annual Report. The dollar amounts spent on research reported in audited reports include operating expenses of the Research Department. Additionally, the dollar amounts also exclude all grants that were cancelled after being awarded, but include money that was returned from grants cancelled in the current year that were awarded in previous years. The dollar amounts reported in the database are unaudited and include grants awarded each fiscal year, exclusive of grants that cancelled before activation.
CBCRP	The California Breast Cancer Research Program grants are awarded only to individuals or institutions in California. Grants to the University of California receive only direct funds, while grants to other institutions also receive indirect costs (overhead) at 25% or the federally negotiated rate. Collaborative awards are counted in graphs and tables by the number of co-Principal Investigators rather than the number of projects.
Komen	Dollar amounts found in the ICRP database are different than what is reported on Komen\'s website or in Komen\'s Annual Report for the following reasons: Komen commits all funds necessary to support a research grant in the year it is awarded. Therefore, Komen\'s website reports on the full amount of each grant in the year it is initiated, while the ICRP data is annualized, as described. Komen funds research grants to our Scientific Advisors (Scientific Advisory Board members and Komen Scholars) and also provides discretionary funding of research-related projects that are not traditional research grants (e.g. support of the Komen Tissue Bank, ASCO and AACR meeting support). These are included in the overall Research Program spending, as reported in our Annual Report and on our website, but are not included in the ICRP database.
NIH	NIH projects in NIH Reporter assigned to the Spend Category ‘cancer’ are included in the ICRP database from FY2005 onwards. A small number of projects are excluded if essential information is missing (primarily Project title, Institution). Previous years’ data were drawn from the NFRP and may be incomplete. Starting in FY2007 NCI reports funding supplements, etc., for each grant separately instead of including them in the main project, therefore the number of projects may differ significantly from those of previous years. Projects with a cost of $0 include those that were a no-cost extension of the grant or when funding was provided by another NIH institute or center for that FY. NCI dollars in the ICRP database are drawn from NIH reporter and may not match dollars from other NCI-only databases.
Worldwide Cancer Research	Worldwide Cancer Research is unique in that the majority of our funding is awarded to researchers in countries outside the UK. Like many UK research charities, Worldwide Cancer Research only funds the direct costs of research. This creates significant problems in making quantitative comparisons between our funding and that provided by some of the other agencies in the ICRP, which fund both the direct and indirect costs (often called overheads) of research.

UK Organizations that are part of NCRI
Partner	Caveat
NCRI (GENERIC)	NCRI submits data to ICRP on behalf of all UK NCRI members from its Cancer Research Database (CaRD). The database only includes entries where funding can be directly attributed to a set of clearly defined research objectives. This means that the CaRD only contains information on all direct research funding (project, programme, fellowship, unit and institute) financed by NCRI Member organizations, for which an abstract has been submitted and where the project is active in any given financial year (April - March). Examples of funding that are currently outside the scope of CaRD are infrastructure, meeting grants and research management support."
Breakthrough (UK)	The ICRP database includes all Breakthrough Breast Cancer\'s research spend reported through its Annual Reports & Accounts. There is some variance due to different reporting periods (1 April snapshot versus full financial year) meaning that some research spend that is already committed may not be included in the ICRP figures. Expenditure on non-research charitable activities and management support costs are excluded from the NCRI, and by extension, the ICRP dataset. For further information on Breakthrough\'s research please visit www.breakthroughresearch.org.uk or email research@breakthrough.org.uk
CR-UK (UK)	The ICRP database includes around 70% of Cancer Research UK\'s direct research spend per financial year as reported through its Annual Reports & Accounts. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on vital research services, technology transfer, meeting grants, research management support and infrastructure to support Cancer Research UK\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Department of Health (UK)	There will always be some variance between the figures available on ICRP and the figures reported publicly by DH. There are two reasons for this. Firstly, there is variance due to different reporting periods (1 April snapshot of ICRP versus full financial year reporting by DH). Secondly, the Department\'s National Institute for Health Research (NIHR) encompasses various expenditure on NHS infrastructure for research relevant to cancer that is not in a format that it is possible to capture for ICRP.
Macmillan (UK)	The ICRP database represents about 90% of Macmillan Cancer Support\'s direct research spend per financial year. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on research management support and infrastructure to support Macmillan Cancer Support\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Scottish Government Health Directorates (UK)	Scottish Government is committed to improve the health of the Scottish population and the Chief Scientist\'s Office (CSO) funds across a broad range of relevant disease areas. Overall, 75% of the CSO spend is committed to research infrastructure in NHS Scotland. This and much other research expenditure is therefore outside the NCRI remit and, by extension, the ICRP dataset.

Canadian organizations who are part of the CCRA
Partner	Caveat
CCRA	Caveats/limitations specific to Canadian Cancer Research Alliance organizations can be accessed here.

Difference	Detail	Impact on investment figures
Not all CCRS participating organizations are included in the ICRP.	For the period 2005–2021, CCRA submitted data to the ICRP for 35 organizations and three now defunct multi-funded initiatives (CBCRA, CPCRI, and CTCRI). Note that the Canadian Breast Cancer Research Foundation merged operations with the Canadian Cancer Society in February 2017 and Prostate Cancer Canada merged in 2020. Importantly, Alberta Innovates did not report any research projects for 2020 and 2021 due to staffing constraints. Projects within the CCRS total 30,218, of which 24,129 were reported to ICRP.	Moderate for years 2020 and 2021
Not all CCRS projects are included in the ICRP.	“Related support” grants (i.e., travel awards, workshops/symposia, LOIs, etc.) are not submitted to ICRP, but are included in reports released by CCRA. In addition, equipment/infrastructure grants through the Canada Foundation for Innovation and for other funders where the cancer relevance weighting is less than 80% are not reported to the ICRP, but are included in CCRA reports. Any project with cancer relevance of less than 20% is also not reported to the ICRP.	Moderate
Co-funded projects are listed by the administering organization.	Projects that are co-funded appear under the administering organization and are not duplicated per funder. Within CCRA reports, however, investments are reported by the actual funders.	Minor
ICRP uses a different approach to calculating annual project investment.	CCRA provides ICRP with the project budget (adjusted for cancer relevance) and start and end dates. A pro-rated calculation is used to derive annual investment. Within the CCRS, prorated calculations on the basis of annual project amounts (where those data are available) are used to calculate the annual investment.	Minor
ICRP uses different site coding conventions.	The cancer site/type codes used within the CCRS are different from ICRP site codes so results by site will vary in some instances.	Minor
ICRP has technical limitations.	ICRP has a technical limit of 12 site codes and 8 CSO codes and this requires truncation for a couple of large-scale projects within the CCRS.	Very minor
CCRA provides less descriptive information about its projects to ICRP.	Lay abstracts are submitted by CCRA to the ICRP in lieu of technical abstracts and in their language of origin. For projects without lay abstracts (and there are a significant number of these), only titles are provided. An English translation is provided alongside all French project titles to facilitate use of the search engine.	No impact on investment figures, but limits full functionality of search engine especially for organizations that do not collect/report lay abstracts.